A new but very expensive breast cancer drug has shown “unprecedented” benefits in extending the lives of women with an aggressive form of the disease.
Data released by the pharmaceutical company Roche suggests Perjeta could, in combination with other drugs, increase the survival of women with advanced breast cancer by 15 months. The results will raise the stakes in the battle in the UK over the funding of cancer drugs.
Perjeta was turned down in principle by the National Institute for Health and Care Excellence (Nice) for routine NHS use last year, but women can obtain it if their doctor applies to the Cancer Drugs Fund, set up by the government to take the political heat out of the question of access to expensive new cancer medicines.
A best friend is a reservoir of wisdom, offering insights garnered from their own experiences. They pass on knowledge that is often more valuable than any textbook. https://statusraja.in/friendship-whatsapp-status-video-download/